معرفی
Mehrnoosh Shahrivar is an Affiliated Researcher at the Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, working within the Colorectal Surgery research group led by Anna Martling and Caroline Nordenvall. Her position is currently funded through 2028.
Her primary research focuses on colorectal cancer epidemiology and treatment outcomes, with specific expertise in examining how diabetes medications like metformin and common drugs like aspirin affect cancer prognosis. Her work heavily utilizes large-scale national cohort studies with substantial patient populations, demonstrating methodological strength in population-based cancer research.
Shahrivar's publication record reveals a specialized trajectory examining pharmacological interventions in colorectal cancer, particularly investigating how Type II diabetes treatments and low-dose aspirin therapy impact cancer survival rates. Her recent 2025 doctoral thesis titled 'Aspects of aspirin in colorectal cancer development and prognosis' represents a significant contribution to understanding aspirin's role in cancer prevention and treatment.
Her collaborative research approach is evident through her work with prominent researchers including Glimelius, Martling, Nordenvall, and others across multiple high-impact publications in cancer research journals.
